MedPath

Effect of oral supplementation of zinc on treatment of otitis media with effusion”

Phase 2
Conditions
Otitis Media with effusion.
Nonsuppurative otitis media, unspecified
H65.9, H65
Registration Number
IRCT138809292893N1
Lead Sponsor
Shahed University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
52
Inclusion Criteria

Patients were excluded if they had any of the followings: ruptured tympanic membrane and otorrhea, a history of hypersensitivity to penicillin or zinc derivatives, antimicrobial treatment in the preceding 30 days, diseases such as sinusitis or pneumonia or anemia, recent episode of acute otitis media, previous adenoidectomy or ventilation tube insertion, compromised immunity or any pathology of the ear, nose and throat or factors that could preclude completion of treatment

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Tympanic membrane status. Timepoint: baseline, 3 weeks, 6 weeks. Method of measurement: examination.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath